on 31 Dec 1969
Last Applicant/ Owned by
Reata Pharmaceuticals Inc.
2801 Gateway Drive, Suite 150Irving TX 75063
US
Serial Number
2141657 filed on 24th Aug 2021
Registration Number
TMA1246221 registered on 26th Jul 2024
Registration expiry Date
24th Aug 2031Correspondent Address
1100-150 York StreetToronto
ONTARIO
CA
M5H3S5
Trademark usage description
pharmaceutical preparations for the treatment of renal, cardiovascular, and metabolic diseases and disorders, namely, diabetes and complications from Read More11
2141657
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 14th Feb 2023 | Search Recorded |
Submitted for opposition 20 on 14th Feb 2023 | Examiner's First Report |
Submitted for opposition 67 on 07th Oct 2022 | Agent Name Changed |
Submitted for opposition 256 on 22nd Aug 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 19th Jan 2022 | Agent Changed |
Submitted for opposition 257 on 21st Oct 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 20th Oct 2021 | Formalized |
Submitted for opposition 1 on 20th Oct 2021 | Created |
Submitted for opposition 228 on 24th Aug 2021 | International Registration |
Submitted for opposition 30 on 24th Aug 2021 | Filed |